The PI3K/Akt/mTOR pathway plays a fundamental role in cell proliferation, survival and development [69], and is altered in breast cancer [70]; therefore, efforts have focused on trying to inhibit the various components that make up this signaling pathway. This evidence concerns the gene AKT1 and breast cancer.